EUROFINS SCIENT Other Non-Cash Items 2018-2024 | ERFSF
EUROFINS SCIENT annual/quarterly other non-cash items history and growth rate from 2018 to 2024. Other non-cash items can be defined as miscellaneous non-cash adjustments to Net income.
- EUROFINS SCIENT other non-cash items for the quarter ending December 31, 2024 were $0M, a 0% increase year-over-year.
- EUROFINS SCIENT other non-cash items for the twelve months ending December 31, 2024 were $0.134B, a 0% increase year-over-year.
- EUROFINS SCIENT annual other non-cash items for 2024 were $0.307B, a 21.34% increase from 2023.
- EUROFINS SCIENT annual other non-cash items for 2023 were $0.253B, a 106.06% increase from 2022.
- EUROFINS SCIENT annual other non-cash items for 2022 were $0.123B, a 65.88% decline from 2021.
| EUROFINS SCIENT Annual Other Non-Cash Items (Millions of US $) |
|
|---|---|
| 2024 | $307 |
| 2023 | $253 |
| 2022 | $123 |
| 2021 | $360 |
| 2020 | $281 |
| 2019 | $190 |
| 2018 | $140 |
| 2017 | $78 |
| 2016 | $N/A |
| 2015 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.266B | $7.522B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.512B | 27.48 |
| Elevance Health (ELV) | United States | $86.065B | 11.11 |
| CVS Health (CVS) | United States | $83.137B | 10.33 |
| Cencora (COR) | United States | $55.558B | 19.33 |
| DiDi Global (DIDIY) | China | $23.015B | 24.45 |
| Natera (NTRA) | United States | $22.771B | 0.00 |
| BioMerieux (BMXMF) | France | $16.981B | 0.00 |
| Solventum (SOLV) | United States | $12.874B | 13.63 |
| ICON (ICLR) | Ireland | $11.753B | 10.93 |
| CochLear (CHEOY) | Australia | $11.492B | 0.00 |
| Revvity (RVTY) | United States | $11.324B | 19.49 |
| Doximity (DOCS) | United States | $10.794B | 49.97 |
| Viatris (VTRS) | United States | $10.540B | 3.62 |
| Avantor (AVTR) | United States | $9.213B | 13.39 |
| HealthEquity (HQY) | United States | $9.042B | 39.61 |
| Medpace Holdings (MEDP) | United States | $8.689B | 23.08 |
| Sonic Healthcare (SKHHY) | Australia | $8.397B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.422B | 14.54 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.425B | 26.06 |
| BrightSpring Health Services (BTSG) | United States | $3.848B | 35.31 |
| Sotera Health (SHC) | United States | $3.423B | 19.45 |
| Alignment Healthcare (ALHC) | United States | $3.055B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.969B | 38.62 |
| Concentras Parent (CON) | United States | $2.811B | 16.24 |
| Organon (OGN) | United States | $2.620B | 2.78 |
| GeneDx Holdings (WGS) | United States | $2.006B | 77.28 |
| Ardent Health (ARDT) | United States | $1.908B | 8.13 |
| Progyny (PGNY) | United States | $1.859B | 40.92 |
| Premier (PINC) | United States | $1.853B | 14.06 |
| GoodRx Holdings (GDRX) | United States | $1.618B | 32.36 |
| PACS (PACS) | United States | $1.615B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.302B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.222B | 9.29 |
| CareDx (CDNA) | United States | $1.118B | 17.46 |
| Establishment Labs Holdings (ESTA) | $1.114B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.948B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.844B | 7.90 |
| QDM (QDMI) | Hong Kong, SAR China | $0.763B | 0.00 |
| Nutex Health (NUTX) | United States | $0.671B | 10.16 |
| Embecta (EMBC) | United States | $0.591B | 3.98 |
| LifeMD (LFMD) | United States | $0.574B | 0.00 |
| Enhabit (EHAB) | United States | $0.519B | 42.71 |
| InnovAge Holding (INNV) | United States | $0.514B | 0.00 |
| SBC Medicals (SBC) | United States | $0.481B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.474B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.462B | 10.40 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.429B | 0.00 |
| Oncology Institute (TOI) | United States | $0.255B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.252B | 0.00 |
| Beauty Health (SKIN) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.156B | 25.50 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| KindlyMD (NAKA) | United States | $0.111B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.109B | 0.00 |
| So-Young (SY) | China | $0.091B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.077B | 0.00 |
| OncoCyte (OCX) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.058B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.052B | 0.00 |
| OpGen (OPGN) | United States | $0.050B | 0.00 |
| Biodesix (BDSX) | United States | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |